Abstract
895P Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have